WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday issued proposed guidelines for the pharmaceutical and medical device industries for posting information on social media networks and correcting misinformation posted by others.
The long-awaited guidance would effectively limit the amount of product advertising a company can do on sites where character space is limited, such as Twitter.
Image: http://medcitynews.com/
To read the original article: Finally! FDA proposes social media guidelines for pharma & medical device makers
